Redefining Neurodevelopmental Impairment: Perspectives of Very Preterm Birth Stakeholders.
neurodevelopment
outcomes
patient-oriented research
prematurity
stakeholders
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
14 May 2023
14 May 2023
Historique:
received:
14
04
2023
revised:
05
05
2023
accepted:
08
05
2023
medline:
27
5
2023
pubmed:
27
5
2023
entrez:
27
5
2023
Statut:
epublish
Résumé
Children born very preterm are at risk of severe neurodevelopmental impairment, a composite endpoint that includes cerebral palsy, developmental delay, and hearing and visual impairment defined by medical professionals. We aimed to describe preterm birth stakeholders' perspectives on this classification. Ten clinical scenarios describing 18-month-old children with different components of severe neurodevelopmental impairment and one scenario of a typically developing child (control) were distributed to parents and stakeholders using a snowball sampling technique. For each scenario, participants rated health on a scale from 0 to 10 and whether the scenario represented a severe condition. Results were analyzed descriptively and mean differences from the control scenario were compared using a linear mixed-effects model. Stakeholders (number = 827) completed 4553 scenarios. Median health scores for each scenario varied from 6 to 10. The rating for the cerebral palsy and language delay scenario was significantly lower (mean difference -4.3; 95% confidence interval: -4.4, -4.1) than the control. The proportion of respondents rating a scenario as "severe" ranged from 5% for cognitive delay to 55% for cerebral palsy and language delay. Most participants disagreed with the rating used in research to describe severe neurodevelopmental impairment in preterm children. The term should be redefined to align with stakeholder perceptions.
Identifiants
pubmed: 37238428
pii: children10050880
doi: 10.3390/children10050880
pmc: PMC10217698
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : CIHR
ID : SCA-145104
Pays : Canada
Références
Arch Dis Child Fetal Neonatal Ed. 2011 May;96(3):F225-32
pubmed: 20488863
Semin Perinatol. 2022 Nov;46(7):151636
pubmed: 35835614
J Pediatr. 2018 Sep;200:58-63.e1
pubmed: 29705117
BMJ. 2010 Aug 18;341:c3920
pubmed: 20719825
J Clin Epidemiol. 2007 Jul;60(7):651-7; discussion 658-62
pubmed: 17573977
JAMA. 2012 Jan 18;307(3):275-82
pubmed: 22253394
Arch Dis Child Fetal Neonatal Ed. 2020 May;105(3):232-239
pubmed: 31980443
Arch Dis Child Fetal Neonatal Ed. 2017 May;102(3):F235-F234
pubmed: 27758929
Dev Med Child Neurol. 1997 Apr;39(4):214-23
pubmed: 9183258
JAMA Pediatr. 2020 May 1;174(5):e196294
pubmed: 32119065
JAMA. 2022 Jan 18;327(3):248-263
pubmed: 35040888
J Pediatr. 2016 Feb;169:61-8.e3
pubmed: 26561378
BMJ. 2005 Mar 12;330(7491):594-6
pubmed: 15761002
J Pediatr. 2018 Jun;197:75-81.e4
pubmed: 29398054
Acta Paediatr. 2023 Mar;112(3):398-408
pubmed: 36479723
CMAJ. 2021 Aug 3;193(30):E1164-E1172
pubmed: 34344771
Int J Gynaecol Obstet. 2020 Jul;150(1):31-33
pubmed: 32524596
Early Hum Dev. 2013 Apr;89(4):209-13
pubmed: 23462550
Ment Retard Dev Disabil Res Rev. 2002;8(4):221-33
pubmed: 12454898
Paediatr Child Health. 2019 Nov 29;26(1):e46-e51
pubmed: 33542778
Arch Dis Child. 1958 Feb;33(167):10-8
pubmed: 13509737
Acta Paediatr. 2008 Mar;97(3):276-9
pubmed: 18298773
Clin Neuropsychol. 2017 Feb;31(2):371-381
pubmed: 27687612
Arch Dis Child Fetal Neonatal Ed. 2022 Sep;107(5):495-500
pubmed: 34815239
Semin Perinatol. 2022 Mar;46(2):151551
pubmed: 34893335
Res Dev Disabil. 2013 Nov;34(11):4103-14
pubmed: 24055712
Arch Dis Child Fetal Neonatal Ed. 2020 Jul;105(4):425-431
pubmed: 31732683